Twenty state attorneys general press Rubio on Chinese GLP-1 ingredient imports
Letter cites FDA's Green List and a warning letter to Harbin Jixianglong, which repackaged non-Green List semaglutide and altered manufacturing dates.
DO
By Daniel Okafor · Regulatory Correspondent
Sep 24 11:28 ETSource: DeSoto County News
The wire
- 01Mississippi AG Lynn Fitch joined 19 other attorneys general in a letter to Secretary of State and National Security Advisor Marco Rubio urging safeguards against unverified Chinese API entering the US supply chain.
- 02The letter names semaglutide, tirzepatide and retatrutide APIs used in compounded GLP-1s, and says some Chinese firms tied to fentanyl manufacturers now sell cosmetic and weight-loss peptides.
- 03FDA authorized the Green List of suppliers in September 2025; the Harbin case showed listed firms can still relabel off-list product, discovered only on an on-site inspection.
From the source
Read at desotocountynews.comAG Fitch Urges Administration to Protect GLP-1 Drugs from Chinese Exploitation
(Jackson, Mississippi) — Ahead of Xi Jinping’s meeting with the President, Attorney General Lynn Fitch joined a 20-state letter to Secretary of State and National Security Advisor Marco Rubio urging the administration to guard against Chinese efforts to introduce low-quality and unsafe pharmaceutical ingredients to the U.S. pharmaceutical supply chain, given recent reports of Chinese-source busine
